Trial NCT00666497

View at ClinicalTrials.gov 
Org. Study IDs: 103 PH GL 2007 CL003

Last trial update was posted on 2015-05-08

MeSH Interventions

Azacitidine Mocetinostat

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Preleukemia Syndrome

Other Conditions

Acute Myeloid Leukemia (AML) Myelodysplastic Syndrome (MDS)

Stopping Reasons

Celgene terminated its collaboration agreement with MethylGene for the development of MGCD0103. All Celgene-sponsored trials with MGCD0103 with be closed.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID